ALS

Business

Amylyx stock gains as it pulls ALS therapy Relyvrio

chrupka/iStock via Getty Images Amylyx Pharmaceuticals (NASDAQ:AMLX) on Thursday formally announced its decision to withdraw Relyvrio, an FDA-approved therapy for…

Read More »
Science

Movement disorder ALS and cognitive disorder FTLD show strong molecular overlaps, new study shows

On the surface, the movement disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and the cognitive disorder…

Read More »
Politics

Ady Barkan, health care activist, dies of ALS at 39 : NPR

Ady Barkan speaks at the premiere of his documentary Not Going Quietly in August 2021 in Los Angeles. Vivien Killilea/Getty…

Read More »
Back to top button